Investing
Here’s a quick recap of the crypto landscape for Wednesday (April 23) as of 9:00 p.m. UTC. Get the latest insights on Bitcoin, Ethereum...
Hi, what are you looking for?
(TheNewswire) April 24th, 2025 TheNewswire – Vancouver, B.C. Opawica Explorations Inc . (TSXV: OPW) (FSE: A2PEAD) (OTC: OPWEF) (the ‘Company’ or ‘Opawica’), a Canadian...
Here’s a quick recap of the crypto landscape for Wednesday (April 23) as of 9:00 p.m. UTC. Get the latest insights on Bitcoin, Ethereum...
NorthStar Gaming Holdings Inc. (TSXV: BET) (OTCQB: NSBBF) (‘NorthStar’ or the ‘Company’) has announced a change of date for its upcoming Q4 and Year-End...
Lode Gold Resources Inc. (TSXV: LOD) (OTCQB: SBMIF) (‘Lode Gold ‘ or the ‘Company’) is pleased to announce its wholly-owned subsidiary, (‘1475039 B.C. Ltd.’...
Pierre Gratton, president and CEO of the Mining Association of Canada, gave his annual address in front of members of the association and the...
Constellation Energy (NASDAQ:CEG) plans to revive Three Mile Island (TMI) Unit 1 under a 20 year power purchase agreement with Microsoft (NASDAQ:MSFT) announced on...
Element 25 Limited (E25 or Company) (ASX: E25; OTCQX: ELMTF) is pleased to announce it has been selected for award negotiations for a US$166...
Quetzal Copper Corp. (TSXV: Q) (‘Quetzal’ or the ‘Company’) is pleased to provide an update that it received a permit that allows drilling to...
‘You can’t say gold is at a high — you have to look at why, at what brings it to this number and is...
ChemX Materials (ASX:CMX) (ChemX or the Company), an Australian high purity critical materials company and 100%-owner of the HiPurA® patented process to produce High...
Description The securities of Nordic Nickel Limited (‘NNL’) will be placed in trading halt at the request of NNL, pending it releasing an announcement....
Jupiter Energy Limited (“Jupiter” or “the Company”) is pleased to provide this update regarding progress in some important areas of its operations. KEY POINTS:...
Amplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”), is pleased to announce that the Company’s Phase 2a clinical trial investigating narmafotinib in the...